Abstract:3070 Background: Patients with pulmonary nodules undergoing excessive invasive procedures is a pressing clinical problem. We sought to develop a noninvasive, machine learning-based multidimensional tool combining clinical, radiomic, and cell-free DNA (cfDNA) methylation biomarkers for improving accuracy of pulmonary nodules classification. Methods: This prospectively collected and retrospective blinded evaluation trial enrolled a total of 1,276 subjects at 24 hospitals in China. All patients with a 5-30 mm pulmonary nodule at high risk of lung cancer had undergone surgical resection with definitive pathological diagnosis. Clinical information, preoperative peripheral blood, and chest CT scans were collected. The regions of interest (ROIs) containing target nodule on the CT images were automatically segmented by a deep-learning based model. 2,153 radiomics features were extracted from ROIs using PyRadiomics. Based on clinical and radiomics features, four classification models were constructed using LightGBM, Lasso, Random Forest, and Logistic Regression algorithms. Subsequently, the predicted probabilities of the above four models were averaged to obtain a final score of the combined clinical and radiomic biomarkers model (CRBM) in a training set (n=797). Then we integrated CRBM model with our previously established cfDNA methylation model (PulmoSeek; DOI: 10.1172/JCI145973) to create a new combined model using logistic regression (n=201), PulmoSeek Plus V2.0, and verified it independently (n =278). The ROC curves were compared to evaluate the diagnostic performance among the CRBM, PulmoSeek, and PulmoSeek Plus V2.0 model, pathologic diagnosis as the gold standard. Results: The CRBM model achieved AUCs of 0.81(95%CI 0.73-0.90) and 0.80 (0.74-0.86) in the two validation sets (n1=201, n2=278), respectively. In the training set (n=201) and validation set (n=278), the PulmoSeek Plus V2.0 obtained AUCs of 0.93 (0.90-0.97) and 0.91 (0.88-0.95), and accuracies of 0.89 (0.84-0.93) and 0.84 (0.79-0.88), respectively. In the combined set (n=479), when compared with CRBM and PulmoSeek, PulmoSeek Plus V2.0 yielded improved AUCs of 11% and 6%, and accuracies of 6% and 3%, respectively. PulmoSeek Plus V2.0 model for rule-out at the fixed specificity of 50%, had an overall sensitivity of 0.98 (0.96-0.99), PPV of 0.86 (0.82-0.89), and NPV of 0.998 (0.988-1.000, at 5% prevalence). It maintains good diagnostic performance in early-stage lung cancer (0-I, n=328) and 5-10 mm nodules (n=92), with sensitivities of 0.98 (0.96-0.99) and 0.98 (0.92-0.99), respectively. Conclusions: PulmoSeek Plus V2.0, as a novel machine learning-based multidimensional model, improves the accuracy of pulmonary nodules classification, and potentially reduces the unnecessary invasive procedures among individuals with benign nodules. Clinical trial information: NCT03181490 , NCT03651986 .

Development of a machine learning model for predicting pneumothorax risk in coaxial core needle biopsy (≤3 cm)

Machine-Learned Algorithms to Predict the Risk of Pneumothorax Requiring Chest Tube Placement after Lung Biopsy

Development and validation of a prediction model of pneumothorax after CT-guided coaxial core needle lung biopsy

A predictive model for post-thoracoscopic surgery pulmonary complications based on the PBNN algorithm

A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules

Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data

Establishment and validation of multiclassification prediction models for pulmonary nodules based on machine learning

Predicting Benign, Preinvasive, and Invasive Lung Nodules on Computed Tomography Scans Using Machine Learning

Prediction of Postoperative Cardiopulmonary Complications after Lung Resection in a Chinese Population: A Machine Learning-Based Study

Development of a hemoptysis risk prediction model for patients following CT-guided transthoracic lung biopsy

CT and CEA‐based Machine Learning Model for Predicting Malignant Pulmonary Nodules

Development and Validation of a Random Forest Risk Prediction Pneumothorax Model in Percutaneous Transthoracic Needle Biopsy

Development and Validation of a Deep Learning Radiomics Model to Predict High-Risk Pathologic Pulmonary Nodules Using Preoperative Computed Tomography

Construction of a risk prediction model for lung infection after chemotherapy in lung cancer patients based on the machine learning algorithm

A deep learning approach for predicting visceral pleural invasion in cT1 lung adenocarcinoma

Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma

A machine learning–based multidimensional model integrating clinical, radiomics, and cell-free DNA methylation biomarkers for the classification of pulmonary nodules.

The Value of Radiomics Features Based on HRCT in Predicting whether the Lung Sub-Centimeter Pure Ground Glass Nodule is Benign or Malignant

Application value of the automated machine learning model based on modified CT index combined with serological indices in the early prediction of lung cancer

Development of a machine learning algorithm to predict complications of total laparoscopic anterior resection and natural orifice specimen extraction surgery in rectal cancer

Development of a Risk Prediction Model to Estimate the Probability of Malignancy in Pulmonary Nodules Being Considered for Biopsy